That Progesterone Cream From TikTok Won’t Fix Perimenopause

Your periods are arriving whenever they feel like it, sleep has become a distant memory, and your mood is doing things it has never done before. A video appears on your For You page: a confident woman holds up a small jar and says this “natural bioidentical progesterone cream” sorted her out in two weeks — no prescription required. She has 400,000 likes. You add the cream to your cart.

Before that package arrives, read this.

The claim that is doing the rounds

The story goes like this: progesterone drops during perimenopause; rubbing a “bioidentical” progesterone cream onto your skin tops it back up naturally; because it is “natural” and “hormone-free” (a phrase that appears on some labels, despite containing a hormone), it is both safe and effective without needing a doctor.

This claim is everywhere — TikTok, Instagram, Facebook wellness groups, and increasingly the shelves of South African pharmacies and online supplement stores. The products are often sold as cosmetics, not medicines, which is precisely why they require no prescription and face no meaningful regulatory scrutiny.

Here is the problem: the scientific premise behind the claim is wrong on almost every important point.

Why “bioidentical” is a marketing word, not a medical one

Before unpacking the evidence, it helps to dismantle the word “bioidentical.” The South African Menopause Society’s 2023 statement on compounded bioidentical menopausal hormone therapy states plainly that “‘bioidentical’ is not a scientific term.” It is a marketing term, used by compounding pharmacists and some practitioners to describe hormones with the same molecular structure as the hormones your body produces. That molecular similarity sounds reassuring — but it tells you nothing about how the product is made, what dose you are actually getting, or whether it reaches the right tissues at a therapeutic level.

The major hormonal ingredients that appear in these creams — oestradiol and progesterone — are already available in regulated, South African Health Products Regulatory Authority-registered medicines, with tested purity, potency, and safety data. The “bioidentical” label does not add anything clinically meaningful. It adds marketing appeal.

What actually happens when progesterone meets your skin

Your skin is designed to keep things out. Applying a progesterone cream and expecting a predictable hormonal effect is more complicated than the labels suggest. A review published in the Journal of Obstetrics and Gynaecology found that transdermal progesterone cream absorption is inconsistent: some progesterone accumulates in fat tissue rather than circulating in the bloodstream, and blood levels — the levels that count clinically — can be highly variable from woman to woman and even from day to day in the same woman.

The South African Menopause Society’s 2014 consensus position statement, published in the South African Medical Journal, puts it plainly: “The absorption of bioidentical progesterone cream is variable, unpredictable and unreliable.” The society goes further, stating that its use for opposing the effects of oestrogen on the endometrium — the lining of the uterus — is therefore not recommended.

That endometrial protection point matters a great deal. If you have a uterus and you take oestrogen without adequate progesterone to oppose it, oestrogen stimulates the uterine lining to keep thickening. Over time, without adequate opposition, this can progress to endometrial hyperplasia and, in some cases, endometrial cancer. Progesterone cream applied to the skin cannot reliably deliver enough progesterone to blood and uterine tissue to prevent this. The British Menopause Society’s 2022 guidance confirms the same finding: transdermal cream has “variable absorption with fluctuating tissue availability” that may not provide sufficient endometrial protection. No South African long-term safety data exist for over-the-counter progesterone cream use. The South African Menopause Society notes that no long-term safety studies for compounded bioidentical hormone therapy exist at all.

To put the risk in concrete terms: unopposed oestrogen exposure roughly doubles the risk of endometrial cancer compared to combined oestrogen-plus-progesterone therapy. Using a progesterone cream and believing you are protected when you are not is not a neutral choice.

What about the symptoms — does the cream do anything?

Here is where the picture becomes more nuanced. Some women do report feeling better on progesterone cream. Some of that may be a genuine placebo effect, which is not trivial — placebo response rates in menopause symptom trials often run at 20–30%. Some may reflect the fact that progesterone does penetrate the skin to some degree; it just does so inconsistently.

For over-the-counter creams, no robust, well-designed clinical trials demonstrate meaningful symptom reduction for hot flushes or night sweats. A systematic review catalogued by the Centre for Reviews and Dissemination found insufficient evidence that bioidentical progesterone cream effectively treats menopause-related vasomotor symptoms.

By contrast, oral micronised progesterone — the regulated, South African Health Products Regulatory Authority-registered form, sold in South Africa as Utrogestan — has genuine trial evidence behind it. A 2023 phase three randomised controlled trial published in Scientific Reports tested 300 mg of oral micronised progesterone taken at bedtime against placebo in perimenopausal women. Women taking the progesterone reported significantly improved perceived night sweats (p = 0.023) and significantly better sleep quality (p = 0.005), with reduced interference from perimenopause symptoms in daily life (p = 0.017). The effect on hot flushes measured objectively was modest, but sleep improvement was clear and clinically meaningful. No such trial data exists for the over-the-counter cream.

The regulatory gap between a jar and a prescription

South African data show that approximately 53% of women experience perimenopausal symptoms in their 40s, with the average age of menopause in South Africa sitting at 51.6 years — almost identical to the global average. That is a large group of women who are symptomatic, often for years, and understandably looking for accessible relief.

Regulated menopausal hormone therapy products — including Utrogestan — must pass South African Health Products Regulatory Authority testing for purity, potency, efficacy, and safety before reaching a pharmacist’s shelf. The South African Menopause Society notes that compounded bioidentical hormone therapy products face no such requirement. The US Food and Drug Administration has documented significant aberrations in quality and potency in compounded pharmaceutical products, and there is no reason to assume South African compounded versions are uniformly better controlled.

A jar of progesterone cream bought online or off a pharmacy shelf without a prescription has not had to prove, to any regulator’s satisfaction, that it contains what it says it contains in the amount it says it contains.

Getting the right care in South Africa

In the public sector: Your first stop is your nearest community health centre or clinic. A primary care nurse or general practitioner can assess your symptoms, exclude other causes of cycle irregularity (including thyroid dysfunction, which is common in South African women), and initiate a referral to a gynaecologist at district hospital level if menopausal hormone therapy is indicated. In the Western Cape, the provincial government explicitly provides gynaecological assessment for women with premature or symptomatic menopause through public facilities.

In the private sector: A private general practitioner consultation typically costs R400–R600, and a gynaecologist consultation runs approximately R700 for a standard visit. Some private gynaecologists charge closer to R1,500 for a first comprehensive consultation including history and examination. Utrogestan 200 mg (15 capsules) has a South African maximum approved price of approximately R305 per pack — a month’s supply of oral micronised progesterone at typical perimenopause doses works out to less than most over-the-counter cream products sold online.

Medical aid coverage: Perimenopause treatment is not currently listed as a prescribed minimum benefit condition, meaning your medical aid is not compelled to fund every treatment. However, many open schemes cover gynaecologist consultations and registered medicines from specialist or general practitioner benefits. Check your scheme’s formulary for Utrogestan specifically. Conditions that arise from or complicate perimenopause — such as abnormal uterine bleeding — may trigger prescribed minimum benefit coverage for investigation.

A practical barrier: Load-shedding complicates cold-chain medication storage and can make it harder to attend clinic appointments during peak outage hours. If you are using regulated progesterone that requires stable storage, keep it in a cool, dark place and confirm storage requirements with your pharmacist. Telehealth platforms operating in South Africa now offer menopausal hormone therapy consultations online, which sidesteps some transport and time barriers.

Comorbidity context matters: South Africa carries a substantial burden of hypertension, type 2 diabetes, and human immunodeficiency virus. All three interact with menopausal hormone therapy choices — for example, certain hormone regimens may affect blood pressure or interact with antiretroviral treatment. This is a further reason to have a supervised conversation with a clinician rather than self-managing with an unregulated product.

What to do instead

If your perimenopause symptoms are genuinely disrupting your life, there are evidence-backed options. Oral micronised progesterone (Utrogestan) is South African Health Products Regulatory Authority-registered, has trial evidence for sleep and night sweat improvement, and can be prescribed by a general practitioner. It is not interchangeable with a progesterone cream. If you have been told by a pharmacist or an online seller that a cream is equivalent, it is not — the route of administration fundamentally changes what reaches your bloodstream and your uterine lining.

The South African Society of Obstetricians and Gynaecologists and the South African Menopause Society both endorse individualised, medically supervised menopausal hormone therapy. The conversation is worth having with a clinician.

When to see a doctor

– Cycles becoming irregular, significantly heavier, or more than 7 days long

– Hot flushes or night sweats disrupting work or sleep most nights

– Mood changes severe enough to affect relationships or daily function

– Any unusual or unexpected vaginal bleeding, especially after sex

– You are already using oestrogen in any form without medical supervision

Your general practitioner is the right first point of contact. In the public sector, visit your nearest community health centre.

Bottom line

• Progesterone cream sold over the counter absorbs unpredictably through skin and cannot reliably protect your uterus from oestrogen’s stimulating effect on the endometrial lining.
• The South African Menopause Society explicitly states that transdermal progesterone cream absorption is variable, unpredictable, and unreliable — and warns against its use for uterine protection.
• “Bioidentical” is a marketing term, not a scientific one; regulated, South African Health Products Regulatory Authority-registered progesterone (oral micronised progesterone) already shares the same molecular structure and has actual trial evidence.
• Oral micronised progesterone taken at bedtime has randomised controlled trial evidence for improving night sweats and sleep quality in perimenopausal women; the over-the-counter cream does not.
• See a general practitioner or gynaecologist for supervised perimenopause care; the conversation — and the medication — may cost less than you think.